GGrantIndex
← Search

Cancer Animal Models

$115,612P30FY2017CANIH

Emory University, Atlanta GA

Investigators

Linked publications, trials & patents

Trial NCT07405476Trial NCT07213154Trial NCT07174570Trial NCT07155317Trial NCT07150546Trial NCT07140679Trial NCT07112690Trial NCT07104240Trial NCT07101445Trial NCT06914999Trial NCT06868433Trial NCT06865768Trial NCT06799481Trial NCT06760507Trial NCT06731270Trial NCT06709534Trial NCT06708351Trial NCT06674863Trial NCT06662058Trial NCT06650579Trial NCT06636734Trial NCT06595160Trial NCT06583148Trial NCT06541158Trial NCT06534125Trial NCT06495125Trial NCT06492759Trial NCT06492070Trial NCT06423326Trial NCT06328699Trial NCT06328686Trial NCT06324240Trial NCT06254911Trial NCT06132685Trial NCT06105918Trial NCT06008730Trial NCT06006013Trial NCT05998135Trial NCT05877859Trial NCT05873608Trial NCT05798507Trial NCT05779943Trial NCT05756569Trial NCT05733351Trial NCT05526872Trial NCT05514912Trial NCT05513859Trial NCT05506982Trial NCT05493566Trial NCT05488145Trial NCT05464810Trial NCT05391750Trial NCT05387915Trial NCT05368428Trial NCT05346692Trial NCT05341349Trial NCT05320406Trial NCT05315687Trial NCT05310448Trial NCT05274763Trial NCT05250895Trial NCT05245682Trial NCT05244239Trial NCT05208307Trial NCT05204160Trial NCT05103904Trial NCT05091866Trial NCT05086731Trial NCT05039073Trial NCT05017610Trial NCT04908709Trial NCT04895592Trial NCT04890236Trial NCT04883437Trial NCT04878029Trial NCT04848519Trial NCT04776395Trial NCT04762199Trial NCT04754945Trial NCT04750473Trial NCT04731376Trial NCT04725903Trial NCT04676087Trial NCT04590664Trial NCT04585724Trial NCT04524702Trial NCT04483206Trial NCT04433949Trial NCT04428671Trial NCT04393350Trial NCT04366791Trial NCT04361552Trial NCT04352205Trial NCT04348292Trial NCT04340882Trial NCT04278118Trial NCT04276194Trial NCT04262869Trial NCT04191421Trial NCT04144127

Abstract

CANCER ANIMAL MODELS SHARED RESOURCE PROJECT SUMMARY/ ABSTRACT The Cancer Animal Models Shared Resource (Mouse SR; Categories 1.02, 1.04, 1.06) of Winship Cancer Institute of Emory University (Winship) was established in 2012 to promote cancer discovery by providing expertise to Winship investigators in the development and analysis of animal models of cancer, with a particular focus on genetically engineered mouse models (GEMMs). Since its inception, Mouse SR has supported investigators across all four Winship programs (Cancer Genetics and Epigenetics (CGE), Cancer Cell Biology (CCB), Discovery and Developmental Therapeutics (DDT), and Cancer Prevention and Control (CPC)) with genetic mouse models of colon, prostate, breast, pancreatic, and lung cancer and brain tumors. The number of Winship members actively using Mouse SR increased during the current funding period from seven to twenty- one individual investigators. In 2014, Winship appointed a new Mouse SR Director and added an additional full- time staff member. Mouse SR has expanded its services to include cell-line and patient-derived orthotopic xenograft models and has acquired an IVIS Spectrum pre-clinical optical imaging system. The IVIS Spectrum is capable of detecting high-resolution bioluminescent and fluorescent sources deep within the animal and allows for longitudinal monitoring of therapeutic responses in vivo. Mouse SR provides a significant cost savings to Winship investigators by offering a source of centralized expertise and equipment. Future goals of Mouse SR include establishing immune-competent syngeneic models to support testing of immunotherapies and to establish a bank of GEMM-derived cells lines for rapid in vitro compound screening prior to in vivo studies. During the current funding period, Mouse SR has supported multiple grant applications and awards, contributed to high- impact publications, and supported the successful submission for two new multi-PI R01s and a U01 award. To further support Winship's programmatic initiatives, Mouse SR proposes to: 1) support outstanding cancer research by providing access to high quality services and technologies that promote scientific collaboration and translational potential and 2) provide the outstanding in vivo imaging technologies and associated expertise in support of pre-clinical animal model research.

View original record on NIH RePORTER →